Letters
Long term use of psychiatric drugs
Recommendations in debate on psychiatric drugs are insufficiently justified
BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2952 (Published 02 June 2015) Cite this as: BMJ 2015;350:h2952
- David Tovey, editor in chief, Cochrane1,
- Rachel Churchill, co-ordinating editor, Cochrane Depression, Anxiety, and Neurosis Group2,
- Clive E Adams, co-ordinating editor, Cochrane Schizophrenia Group3,
- Geraldine Macdonald, co-ordinating editor, Cochrane Developmental, Psychosocial, and Learning Problems Group4
- 1London SW1Y 4QX, UK
- 2University of Bristol, Bristol, UK
- 3Institute of Mental Health, University of Nottingham, Nottingham, UK
- 4Queen’s University, Belfast, UK
- dtovey{at}cochrane.org
We are a group of Cochrane editors who are responsible for Cochrane reviews relating to mental health. Like our colleague, Peter Gøtzsche, we are writing in a personal capacity.1
We recognise that Peter has an important record as a renowned methodologist and researcher. However, we believe that in the head to head debate on whether psychiatric drugs cause …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.